UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gene–gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy

The pharmacogenomics journal, 2017-10, Vol.17 (5), p.427-434

2017

Volltextzugriff (PDF)

Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy

The pharmacogenomics journal, 2014-12, Vol.14 (6), p.535-541

2014

Volltextzugriff (PDF)

Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy

The pharmacogenomics journal, 2012-12, Vol.12 (6), p.489-498

2012

Volltextzugriff (PDF)

eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension

The pharmacogenomics journal, 2010-02, Vol.10 (1), p.40-45

2010

Volltextzugriff (PDF)

Haptoglobin polymorphism affects nitric oxide bioavailability in preeclampsia

Journal of human hypertension, 2013-06, Vol.27 (6), p.349-354

2013

Volltextzugriff (PDF)

Maternal iNOS genetic polymorphisms and hypertensive disorders of pregnancy

Journal of human hypertension, 2012-09, Vol.26 (9), p.547-552

2012

Volltextzugriff (PDF)

Polymorphisms of the adiponectin gene in gestational hypertension and pre-eclampsia

Journal of human hypertension, 2014-02, Vol.28 (2), p.128-132

2014

Volltextzugriff (PDF)

Assessment of oxidative status markers and NO bioavailability in hypertensive disorders of pregnancy

Journal of human hypertension, 2013-06, Vol.27 (6), p.345-348

2013

Volltextzugriff (PDF)

Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs genetic polymorphisms and plasma levels in hypertensive disorders of pregnancy

Journal of human hypertension, 2013-04, Vol.27 (4), p.278-279

2013

Volltextzugriff (PDF)

Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia

Molecular human reproduction, 2010-07, Vol.16 (7), p.506-510

2010

Volltextzugriff (PDF)

Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension

Molecular human reproduction, 2009-02, Vol.15 (2), p.115-120

2009

Volltextzugriff (PDF)

PP002. Study of polymorphisms of the adiponectin gene in women with gestational hypertension and preeclampsia

Pregnancy hypertension, 2012-07, Vol.2 (3), p.241-241

2012

Volltextzugriff (PDF)

PP070. Maternal flow-mediated dilation and nitrite concentration during third trimester of pregnancy and postpartum period

Pregnancy hypertension, 2012-07, Vol.2 (3), p.279-279

2012

Volltextzugriff (PDF)

PP071. Evaluation of maternal–fetal doppler parameters and of whole blood nitrite throughout gestation

Pregnancy hypertension, 2012-07, Vol.2 (3), p.279-280

2012

Volltextzugriff (PDF)

Heme Oxygenase-1 Attenuates Hypoxia-Induced sFlt-1 and Oxidative Stress in Placental Villi through Its Metabolic Products CO and Bilirubin

International Journal of Hypertension, 2012-01, Vol.2012 (2012), p.367-372

2012

Volltextzugriff (PDF)

Nitric Oxide Formation Is Inversely Related to Serum Levels of Antiangiogenic Factors Soluble Fms-Like Tyrosine Kinase-1 and Soluble Endogline in Preeclampsia

Hypertension (Dallas, Tex. 1979), 2008-08, Vol.52 (2), p.402-407

2008

Volltextzugriff (PDF)

Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms

American journal of physiology. Regulatory, integrative and comparative physiology, 2015-12, Vol.309 (11), p.R1326-R1343

2015

Volltextzugriff (PDF)

Cell-free DNA as a potential biomarker for preeclampsia

Expert review of molecular diagnostics, 2021-12, Vol.21 (12), p.1253-1256

Palei, Ana C.

2021

Volltextzugriff (PDF)

Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology

Acta Physiologica, 2013-07, Vol.208 (3), p.224-233

2013

Volltextzugriff (PDF)

Immune Mechanisms Linking Obesity and Preeclampsia

Biomolecules (Basel, Switzerland), 2015-11, Vol.5 (4), p.3142-3176

2015

Volltextzugriff (PDF)

Placental Ischemia Says "NO" to Proper NOS-Mediated Control of Vascular Tone and Blood Pressure in Preeclampsia

International journal of molecular sciences, 2021-10, Vol.22 (20), p.11261

2021

Volltextzugriff (PDF)

Matrix metalloproteinases as drug targets in preeclampsia

Current drug targets, 2013-03, Vol.14 (3), p.325-334

2013

Volltextzugriff (PDF)

Circulating microRNA expression profiles in pre‐eclampsia: evidence of increased miR‐885‐5p levels

BJOG : an international journal of obstetrics and gynaecology, 2016-12, Vol.123 (13), p.2120-2128

2016

Volltextzugriff (PDF)

Recent Advances in the Understanding of the Pathophysiology of Preeclampsia

Hypertension (Dallas, Tex. 1979), 2013-10, Vol.62 (4), p.666-673

2013

Volltextzugriff (PDF)

Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre‐eclampsia

Journal of cellular and molecular medicine, 2013-10, Vol.17 (10), p.1300-1307

2013

Volltextzugriff (PDF)

1 – 25 von 122

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(104)

Publikationsform

Sprache

Englisch
(121)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Gene–gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy

Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy

Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy

eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension

Haptoglobin polymorphism affects nitric oxide bioavailability in preeclampsia

Maternal iNOS genetic polymorphisms and hypertensive disorders of pregnancy

Polymorphisms of the adiponectin gene in gestational hypertension and pre-eclampsia

Assessment of oxidative status markers and NO bioavailability in hypertensive disorders of pregnancy

Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs genetic polymorphisms and plasma levels in hypertensive disorders of pregnancy

Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia

Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension

PP002. Study of polymorphisms of the adiponectin gene in women with gestational hypertension and preeclampsia

PP070. Maternal flow-mediated dilation and nitrite concentration during third trimester of pregnancy and postpartum period

PP071. Evaluation of maternal–fetal doppler parameters and of whole blood nitrite throughout gestation

Heme Oxygenase-1 Attenuates Hypoxia-Induced sFlt-1 and Oxidative Stress in Placental Villi through Its Metabolic Products CO and Bilirubin

Nitric Oxide Formation Is Inversely Related to Serum Levels of Antiangiogenic Factors Soluble Fms-Like Tyrosine Kinase-1 and Soluble Endogline in Preeclampsia

Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms

Cell-free DNA as a potential biomarker for preeclampsia

Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology

Immune Mechanisms Linking Obesity and Preeclampsia

Placental Ischemia Says "NO" to Proper NOS-Mediated Control of Vascular Tone and Blood Pressure in Preeclampsia

Matrix metalloproteinases as drug targets in preeclampsia

Circulating microRNA expression profiles in pre‐eclampsia: evidence of increased miR‐885‐5p levels

Recent Advances in the Understanding of the Pathophysiology of Preeclampsia

Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre‐eclampsia

Suchergebnisse filtern